These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2092302)

  • 21. IL-22 Restrains Tapeworm-Mediated Protection against Experimental Colitis via Regulation of IL-25 Expression.
    Reyes JL; Fernando MR; Lopes F; Leung G; Mancini NL; Matisz CE; Wang A; McKay DM
    PLoS Pathog; 2016 Apr; 12(4):e1005481. PubMed ID: 27055194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships of benzothiazole and benzimidazole anthelmintics: a molecular modeling approach to in vivo drug efficacy.
    McCracken RO; Lipkowitz KB
    J Parasitol; 1990 Dec; 76(6):853-64. PubMed ID: 2254820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologically mediated rejection of Hymenolepis diminuta by its normal host, the rat.
    Andreassen J; Hopkins CA
    J Parasitol; 1980 Dec; 66(6):898-903. PubMed ID: 7218109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary infections of Hymenolepis diminuta in mice: effects of varying worm burdens in primary and secondary infections.
    Befus AD
    Parasitology; 1975 Aug; 71(1):61-75. PubMed ID: 1178221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT-6 is an absolute requirement for murine rejection of Hymenolepis diminuta.
    McKay DM; Khan WI
    J Parasitol; 2003 Feb; 89(1):188-9. PubMed ID: 12659328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action of cyclosporin A against Hymenolepis microstoma (Cestoda): relationship between cyclophilin binding and drug-induced damage.
    McLauchlan PE; Roberts HC; Chappell LH
    Parasitology; 2000 Dec; 121 Pt 6():661-70. PubMed ID: 11155937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthelmintic activity of ripe fruit extract of Solanum myriacanthum Dunal (Solanaceae) against experimentally induced Hymenolepis diminuta (Cestoda) infections in rats.
    Yadav AK; Tangpu V
    Parasitol Res; 2012 Feb; 110(2):1047-53. PubMed ID: 21842379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mast cell deficiency in mice results in biomass overgrowth and delayed expulsion of the rat tapeworm
    González MI; Lopes F; McKay DM; Reyes JL
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin E and mast cell responses are related to worm biomass but not expulsion of Hymenolepis diminuta during low dose infection in rats.
    Ishih A; Uchikawa R
    Parasite Immunol; 2000 Nov; 22(11):561-6. PubMed ID: 11116436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hymenolepis microstoma: a change in susceptibility to resistance with increasing age of the parasite.
    Howard RJ
    Parasitology; 1977 Oct; 75(2):241-9. PubMed ID: 927890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anthelmintic efficacy of natural plant cysteine proteinases against Hymenolepis microstoma in vivo.
    Mansur F; Luoga W; Buttle DJ; Duce IR; Lowe A; Behnke JM
    J Helminthol; 2015 Sep; 89(5):601-11. PubMed ID: 25226116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triggering immunological memory against the tapeworm Hymenolepis diminuta to protect against colitis.
    Wang A; Arai T; Campbell A; Reyes JL; Lopes F; McKay DM
    Parasite Immunol; 2017 Nov; 39(11):. PubMed ID: 28892562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine autoimmune arthritis is exaggerated by infection with the rat tapeworm, Hymenolepis diminuta.
    Graepel R; Leung G; Wang A; Villemaire M; Jirik FR; Sharkey KA; McDougall JJ; McKay DM
    Int J Parasitol; 2013 Jun; 43(7):593-601. PubMed ID: 23583716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hymenolepis diminuta: praziquantel removal of adult tapeworms is followed by apoptotic down-regulation of mucosal mastocytosis.
    Starke WA; Oaks JA
    Exp Parasitol; 1999 Jul; 92(3):171-81. PubMed ID: 10403758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed expulsion of Hymenolepis diminuta in Trypanosoma brucei infected mice.
    Fagbemi BO; Christensen NO
    Z Parasitenkd; 1984; 70(5):663-5. PubMed ID: 6506844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of calcineurin from Hymenolepis microstoma and H. diminuta and its interaction with cyclosporin A.
    Roberts HC; Sternberg JM; Chappell LH
    Parasitology; 1997 Mar; 114 ( Pt 3)():279-83. PubMed ID: 9075347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal immunity suppresses carrying capacity of rats for the model tapeworm, Hymenolepis diminuta.
    Ohno T; Kai T; Miyasaka Y; Maruyama H; Ishih A; Kino H
    Parasitol Int; 2018 Aug; 67(4):357-361. PubMed ID: 29448016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosage, timing, and route of administration of cyclosporin A and nonimmunosuppressive derivatives of dihydrocyclosporin A and cyclosporin C against Schistosoma mansoni in vivo and in vitro.
    Chappell LH; Thomson AW; Barker GC; Smith SW
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1567-71. PubMed ID: 3435104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological and histopathological reactions of the rat against the tapeworm Hymenolepis diminuta and the effects of anti-thymocyte serum.
    Hindsbo O; Andreassen J; Ruitenberg J
    Parasite Immunol; 1982 Jan; 4(1):59-76. PubMed ID: 6977126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune stimulation and Hymenolepis nana cysticercoid expulsion in C3H/He and BALB/c mice.
    Gabriele F; Ecca AR; Palmas C
    Parassitologia; 1993 Dec; 35(1-3):55-7. PubMed ID: 8065822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.